Felidiarix
Felidiarix
Authorised
- Sulfaguanidine
- Atropine
- Framycetin
Product identification
Medicine name:
Felidiarix
Active substance:
- Sulfaguanidine
- Atropine
- Framycetin
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Sulfaguanidine50.00/milligram(s)1.00Tablet
-
Atropine0.00/milligram(s)1.00Tablet
-
Framycetin8375.00/international unit(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA07AA99
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Europeenne De Pharmacotechnie Europhartech
Responsible authority:
- Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V 421/02/15/1501
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 10/04/2024
How useful was this page?:
